Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless non-patented drugmakers such as Biocon Ltd. step in to plug the gap in a $34 ...

People with diabetes may use insulin pens, wearable pump devices, or a glass vial and syringe to deliver this needed medication. Costs vary depending on which method you choose. The price of ...

The Diabetes Injection Pens Market is expected to witness a growth rate of ~7% by 2028. The key factors driving the market ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Assembly Bill 555 would prohibit private insurance companies from charging people more than $35 for a 30-day supply of a ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Go-Pen ApS announced recently that it received FDA 510(k) clearance for its Go-Pen cost-effective, user-filled insulin pen.

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...